They are not intended to represent clinical evidence in humans, and Epithalon has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Peptides are generally compatible with many skincare ingredients, but pairing them with strong acidssuch as alpha hydroxy acids (AHAs) or beta hydroxy acids (BHAs)may influence how they interact on the skin.Some peptide formulations may also not pair as well with vitamin C in its active form (ascorbic acid), depending on the product and how its used
But with the right trials, safety profiling, and delivery innovation, it just might be
For cagrilintide specifically, the coming years will determine whether its distinct mechanism can carve out a meaningful roleeither as a standalone therapy through the RENEW program or as part of combination approaches like CagriSema and potentially future pairings Other questions about cagrilintide Because cagrilintide is still in clinical development, many common questions relate to its availability, safety, and how it compares with existing medications